C. de la Fouchardière

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

C. de la Fouchardière

Dec 9, 2024, 13:18 | Insight

Pembrolizumab vs chemotherapy in MSI-high or MMR-deficient metastatic colorectal cancer

Shivani Modi shared a post on X: "Talk of the town! KEYNOTE-177 trial shows mFU: 73.3…

Dec 5, 2024, 09:26 | Blog

Pembrolizumab versus chemotherapy in MSI or dMMR metastatic colorectal cancer

Arndt Vogel shared on X: "Pembrolizumab versus chemotherapy in MSI or dMMR mCRC 5-year follow-up from…

Dec 4, 2024, 17:11 | Opinion

Iván R. González: Results from KEYNOTE-177 after 5 years by Thierry André et al.

Iván R. González, Medical Oncologist at the Comprehensive Cancer Center, Hospital Ángeles Puebla, shared on…

Jul 12, 2024, 17:25 | Insight

PRODIGE23, long term results now published

Krishan Jethwa, Assistant Professor of Radiation Oncology at Mayo Clinic, shared a paper by Thierry…

Jul 11, 2024, 04:05 | Blog

Annals of Oncology - Long-term results of the UNICANCER-PRODIGE 23 trial

Annals of Oncology shared on X: "New article in press: Total neoadjuvant therapy with mFOLFIRINOX versus…

All: 5 Posts: 1 - 100

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

'

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023